Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

Treatment failure and CNS side-effects are associated with low and high efavirenz plasma levels, respectively. The important inter-individual variability in efavirenz levels strongly argues for dose adjustment on the basis of therapeutic drug monitoring to optimize treatment.